| PERIOD ENDING | 3-Apr-09 | 2-Jan-09 | 26-Sep-08 | 27-Jun-08 | | Total Revenue | 553,591 | 508,669 | 570,813 | 512,850 | | Cost of Revenue | 313,200 | 289,712 | 305,807 | 302,312 | | | Gross Profit | 240,391 | 218,957 | 265,006 | 210,538 | | | Operating Expenses | | Research Development | 36,979 | 36,978 | 38,409 | 36,007 | | Selling General and Administrative | 81,183 | 83,233 | 83,855 | 85,269 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 122,229 | 98,746 | 142,742 | 89,262 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 877 | 2,262 | 3,348 | 2,602 | | Earnings Before Interest And Taxes | 123,106 | 101,008 | 146,090 | 91,864 | | Interest Expense | 1,194 | 953 | 1,105 | 1,304 | | Income Before Tax | 121,912 | 100,055 | 144,985 | 90,560 | | Income Tax Expense | 42,554 | 30,476 | 50,751 | 16,380 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 79,358 | 69,579 | 94,234 | 74,180 | | | Non-recurring Events | | Discontinued Operations | (11,545) | (782) | (15,772) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 67,813 | 68,797 | 78,462 | 74,180 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $67,813 | $68,797 | $78,462 | $74,180 |
|
0.45% Nasdaq 
0.20%
Income Statement
